SCHEMBL28299533

SCHEMBL28299533

O=C(O)C1CC(c2ccc(OC(F)F)cc2)=NN(c2cccc(F)c2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
ACSS2 Q9NR19 1/20 0.38
HDAC4 P56524 2/20 0.37
HDAC8 Q9BY41 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
CACNA1H O95180 1/20 0.37
MAOB P27338 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
NR3C2 P08235 3/20 0.36
MAOA P21397 1/20 0.36
ATM Q13315 1/20 0.36
CSNK1E P49674 1/20 0.36
PTGS2 P35354 1/20 0.35
NT5E P21589 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30187450 0.89 KDM4E (0.41) KDM4EACSS2PDE4APDE4BPDE4C
SCHEMBL19642572 0.89 KDM4E (0.41) KDM4EACSS2PDE4APDE4BPDE4C
SCHEMBL28873447 0.88 KDM4E (0.51) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL28297925 0.87 CACNA1H (0.39) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL28297923 0.86 MEN1 (0.41) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL19660389 0.85 PDE4A (0.51) KDM4EACSS2PDE4APDE4BPDE4C
SCHEMBL28299380 0.82 MEN1 (0.49) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL19642610 0.79 KDM4E (0.48) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL30187464 0.79 KDM4E (0.48) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL28297921 0.78 PDE4A (0.46) PDE4APDE4BPDE4CPDE4DMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109863140-A 3- oxo -2,6- diphenyl -2,3- dihydrogen dazin -4- formamide 拜耳医药股份有限公司 2019-06-07 CN disclosed